z-logo
Premium
Synthesis and biological evaluation of 99m Tc(CO) 3 (IDA‐CPT) for tumor imaging
Author(s) -
Wang Jianjun,
Niu Tingting,
Yang Jing,
Tan Cunmin,
Zheng Xiaobei,
Wu Wangsuo,
Dong Feng,
Guo Hongyun
Publication year - 2009
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1690
Subject(s) - biodistribution , chemistry , iminodiacetic acid , linker , camptothecin , in vivo , radiochemistry , methylene , yield (engineering) , norvaline , chelation , stereochemistry , nuclear chemistry , in vitro , medicinal chemistry , biochemistry , organic chemistry , amino acid , materials science , microbiology and biotechnology , computer science , metallurgy , biology , operating system , leucine
This work reports the synthesis, radiolabeling, and preliminary biodistribution results in tumor‐bearing mice of 99m Tc(CO) 3 (IDA‐CPT). The novel camptothecin (CPT) derivate was successfully synthesized by conjugation of iminodiacetic acid (IDA) to camptothecin via a short carbonyl‐methylene linker. Radiolabeling was performed in high yield with [ 99m Tc(CO) 3 ] + core to get 99m Tc(CO) 3 (IDA‐CPT), which was hydrophilic and stable at room temperature. Biodistribution studies in tumor‐bearing mice showed that 99m Tc(CO) 3 (IDA‐CPT) accumulated in the tumor with good uptake and retention. However, its clearance from normal organs was slow, resulting in poor T/NT ratios. Further modification on the linker or/and 99m Tc‐chelate to improve the tumor‐targeting efficacy and in vivo kinetic profiles is currently in progress. Copyright © 2009 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom